ABCDEFGHIJKLMNOPQRSTUV
1
Rack Ae
2
Margaret, Lab Stocks
3
4
Box A1(1-bottom)
5
POSITIONCELL TYPECLONESPECIESTISSUEOWNERFREEZING DATEORIGINPASSAGESPECIFIC FEATURESMEDIUM
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
Box A2
24
POSITIONCELL TYPECLONESPECIESTISSUEOWNERFREEZING DATEORIGINPASSAGESPECIFIC FEATURESMEDIUM
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
Box A3Shailaja
43
POSITIONCELL TYPECLONESPECIESTISSUEOWNERFREEZING DATEORIGINPASSAGESPECIFIC FEATURESMEDIUM
44
NEW
45
DO NOT TRASH1TeloHAEC WTHumanShailaja20/6/2023Shailaja (from Yun Fang)P8Puromycin resistantEGM2
46
2TeloHAEC WTHumanShailaja16/1/2023Shailaja (from Yun Fang)P9Puromycin resistantEGM2
47
3-5TeloHAEC-tet-FHL2-mEmeraldHumanShailajaShailajaP20Sort II; CRISPR, FACS sorted for GFP positive cellsEGM2
48
TeloHAEC-tet-FHL2-mEmeraldHumanShailajaShailajaP22Sort II; CRISPR, FACS sorted for GFP positive cellsEGM2
49
6-8TeloHAEC-tet-FHL2-mEmeraldHumanShailaja8/2/2023ShailajaP23-24Sort III; CRISPR, FACS sorted for GFP positive cellsEGM2
50
9-11TeloHAEC-tet-FHL2-mEmeraldHumanShailaja25/2/2023ShailajaP20Sort IV top 10%; CRISPR, FACS sorted for GFP positive cellsEGM2
51
12TeloHAEC-tet-FHL2-mEmeraldHumanShailaja25/2/2023ShailajaP20Sort IV top 10%; CRISPR, FACS sorted for GFP positive cellsEGM2
52
13-14TeloHAEC-tet-FHL2-F1-4A-mEmeraldHumanShailaja20/6/2023ShailajaP18Sort II top 25%; CRISPR, FACS sorted for GFP positive cellsEGM2
53
15-16HEK293T-SNAP-Zyxin-FLHumanShailaja18/2/2022ShailajaP18? - exact passage written on the tubePuromycin selection; FACS sortedDMEM + 10% FBS
54
17HEK293T-SNAP-Zyxin-LCRHumanShailaja22/2/2022ShailajaP18? - exact passage written on the tubePuromycin selection; FACS sortedDMEM + 10% FBS
55
18-19HEK293T-SNAP-Zyxin-deltaLIMHumanShailaja22/2/2022ShailajaP18? - exact passage written on the tubePuromycin selection; FACS sortedEGM2
56
20TeloHAEC-tet-FHL2-mEmeraldHumanShailaja25/2/2023ShailajaP30Sort IV top 30%; CRISPR, FACS sorted for GFP positive cellsEGM2
57
21HEK293T-SNAP-Zyxin-FLHumanShailaja22/2/2022ShailajaP19Puromycin selection; FACS sortedDMEM + 10% FBS
58
22TeloHAEC-tet-shFHL2-1-CFPHumanShailaja20/6/2023ShailajaP22Sort II; CRISPR, FACS sorted for CFP positive cellsEGM2
59
23TeloHAEC-tet-shFHL2-2-CFPHumanShailaja20/6/2023ShailajaP22Sort III; CRISPR, FACS sorted for CFP positive cellsEGM2
60
24-25TeloHAEC (WT) Stargazin-mem HaloHumanShailajadate written on tube ShailajaP19Sort for GFP positive cellsEGM2
61
26-27TeloHAEC-FHL2-GFP-endogenous-KIHumanShailaja16/1/2024ShailajaP16Sort for GFP positive cellsEGM2
62
28-29TeloHAEC-tet-FHL2-NLS-mEmeraldHumanShailaja3/1/2024ShailajaP15Sort I; CRISPR, FACS sorted for GFP positive cellsEGM2
63
30-31TeloHAEC WTHumanShailaja3/1/2024ShailajaP12Puromycin resistantEGM2
64
32-33TeloHAEC-tet-shFHL2-1-CFPHumanShailaja17/11/2023ShailajaP24Sort II; CRISPR, FACS sorted for CFP positive cellsEGM2
65
34-35TeloHAEC-tet-shFHL2-2-CFPHumanShailaja17/11/2023ShailajaP24Sort III; CRISPR, FACS sorted for CFP positive cellsEGM2
66
36TeloHAEC (WT) Stargazin-mem HaloHumanShailaja2023ShailajaP13Sort using halo549EGM2
67
37-38A388 SCC WTHumanShailaja11/2023ShailajaP5?DMEM + 10% FBS
68
39-40FAT1-KO1-SCC - LindaHumanShailaja11/2023ShailajaP5?DMEM + 10% FBS
69
41-42FAT1-KO2-SCC - AngelaHumanShailaja11/2023ShailajaP5?DMEM + 10% FBS
70
43TeloHAEC-tet-FHL2-NLS-mEmeraldHumanShailajaShailajaP16Sort I; CRISPR, FACS sorted for GFP positive cellsEGM2
71
44TeloHAEC-tet-shFHL2-1-CFPHumanShailaja3/1/2024ShailajaP24Sort II; CRISPR, FACS sorted for CFP positive cellsEGM2
72
45TeloHAEC-tet-shFHL2-2-CFPHumanShailaja3/1/2024ShailajaP24Sort III; CRISPR, FACS sorted for CFP positive cellsEGM2
73
46TeloHAEC-FHL2-GFP-endogenous-KIHumanShailaja19/1/2024ShailajaP16CRISPR, FACS sorted for GFP positive cellsEGM2
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
Box A4
95
POSITIONCELL TYPECLONESPECIESTISSUEOWNERFREEZING DATEORIGINPASSAGESPECIFIC FEATURESMEDIUM
96
97
98
99
100